Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1w84 | L12 | Mitogen-activated protein kinase 14 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
1w84 | L12 | Mitogen-activated protein kinase 14 | / | 1.000 | |
2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.586 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.547 | |
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.544 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.541 | |
1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.537 | |
3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.536 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.532 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.531 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.530 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.528 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.527 | |
3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.527 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.524 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.523 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.522 | |
1oz1 | FPH | Mitogen-activated protein kinase 14 | / | 0.520 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.519 | |
1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.518 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.518 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.517 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.516 | |
3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.515 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.514 | |
2zaz | GK1 | Mitogen-activated protein kinase 14 | / | 0.514 | |
3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.513 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.512 | |
3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.510 | |
1jvs | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.509 | |
4aic | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.509 | |
1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.508 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.508 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.508 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.507 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.507 | |
1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.506 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.506 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.505 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.504 | |
1w7h | 3IP | Mitogen-activated protein kinase 14 | / | 0.501 | |
4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.499 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.498 | |
4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.498 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.497 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.497 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.496 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.496 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.496 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.496 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.494 | |
3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.492 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.492 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.492 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.491 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.491 | |
3fml | FML | Mitogen-activated protein kinase 14 | / | 0.491 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.490 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.490 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.490 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.488 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.488 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.487 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.487 | |
3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.487 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.487 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.486 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.486 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.486 | |
3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.486 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.486 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.485 | |
3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.485 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.484 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.484 | |
3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.483 | |
3nwy | GTP | Uridylate kinase | / | 0.483 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.482 | |
3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.481 | |
3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.481 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.480 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.480 | |
4axf | ANP | Inositol-pentakisphosphate 2-kinase | 2.7.1.158 | 0.480 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.479 | |
2gu8 | 796 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.479 | |
2v9j | ATP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.479 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.479 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.479 | |
3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.479 | |
3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.479 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.479 | |
4cql | NAD | Estradiol 17-beta-dehydrogenase 8 | 1.1.1.62 | 0.479 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.479 | |
4o76 | 1M3 | Bromodomain-containing protein 4 | / | 0.479 | |
1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.478 | |
2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.478 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.478 | |
4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.478 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.478 | |
1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.477 | |
1wbw | LI4 | Mitogen-activated protein kinase 14 | / | 0.477 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.477 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.476 | |
2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.476 | |
2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.476 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.476 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.476 | |
3p5k | P5K | Mitogen-activated protein kinase 14 | / | 0.476 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.476 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.476 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.475 | |
1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.474 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.474 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.474 | |
3q5i | ANP | Protein kinase, putative | / | 0.474 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.474 | |
4beb | ATP | Type I restriction enzyme EcoR124II R protein | 3.1.21.3 | 0.474 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.473 | |
3fpb | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.473 | |
3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.473 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.473 | |
4gb9 | 0WR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.473 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.473 | |
1kij | NOV | DNA gyrase subunit B | / | 0.472 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.472 | |
2cci | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.472 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.472 | |
3mvh | WFE | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.472 | |
3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.472 | |
3s1c | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.472 | |
3zok | NAD | 3-dehydroquinate synthase, chloroplastic | 4.2.3.4 | 0.472 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.472 | |
4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.472 | |
1g1l | DAU | Glucose-1-phosphate thymidylyltransferase | / | 0.471 | |
2vq5 | LDP | S-norcoclaurine synthase | / | 0.471 | |
2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.471 | |
3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.471 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.471 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.471 | |
2c6h | PXI | Cytochrome P450 monooxygenase PikC | / | 0.470 | |
2eau | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.470 | |
2jjx | ATP | Uridylate kinase | / | 0.470 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.470 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.470 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.470 | |
3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.470 | |
3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.470 | |
2f7e | 2EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.469 | |
2vo3 | M04 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.469 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.469 | |
3anl | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.469 | |
3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.469 | |
3t54 | ATP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.469 | |
4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
1zao | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.468 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.468 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.468 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.468 | |
3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.468 | |
1ndz | FR5 | Adenosine deaminase | 3.5.4.4 | 0.467 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
3klj | FAD | NADH-rubredoxin oxidoreductase | 1.18.1.1 | 0.467 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.467 | |
4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.467 | |
1gx1 | CDP | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 4.6.1.12 | 0.466 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.466 | |
3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.466 | |
3fsf | FSS | Mitogen-activated protein kinase 14 | / | 0.466 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.466 | |
3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.466 | |
4cdm | FAD | Deoxyribodipyrimidine photolyase | / | 0.466 | |
4dlj | 6RG | Mitogen-activated protein kinase 14 | / | 0.466 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.466 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.465 | |
3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.465 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.464 | |
2r43 | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.464 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.464 | |
3pp1 | IZG | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.464 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.464 | |
4wbo | ANW | Rhodopsin kinase | / | 0.464 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.463 | |
3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.463 | |
3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.463 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.463 | |
4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.463 | |
1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.462 | |
2uzv | SS5 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.462 | |
3gnq | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.462 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.462 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.462 | |
4ydu | ADP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.462 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.461 | |
1mb9 | ATP | Carboxyethyl-arginine beta-lactam-synthase | 6.3.3.4 | 0.461 | |
1t1s | CBQ | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.461 | |
2cvj | FAD | Thioredoxin reductase related protein | / | 0.461 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.461 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.461 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.461 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.461 | |
3p7b | P7B | Mitogen-activated protein kinase 14 | / | 0.461 | |
3qlx | QLR | Uncharacterized protein | / | 0.461 | |
3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.461 | |
4ei7 | GDP | Plasmid replication protein RepX | / | 0.461 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.461 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.461 | |
1mc5 | AHE | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.460 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
3c5u | P41 | Mitogen-activated protein kinase 14 | / | 0.460 | |
3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.460 | |
3zsg | T75 | Mitogen-activated protein kinase 14 | / | 0.460 | |
4bec | ATP | Type I restriction enzyme EcoR124II R protein | 3.1.21.3 | 0.460 | |
4d4s | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.460 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.460 | |
4nak | PBQ | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase, chloroplastic | 2.7.7.60 | 0.460 | |
4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.460 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.460 | |
1ict | T44 | Transthyretin | / | 0.459 | |
1kgj | FL8 | Transthyretin | / | 0.459 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.459 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
3ugc | 046 | Tyrosine-protein kinase JAK2 | / | 0.459 | |
4c9p | CAM | Cytochrome P450 | / | 0.459 | |
4v12 | POG | MaoC like domain protein | / | 0.459 | |
1pdh | FAS | p-hydroxybenzoate hydroxylase | / | 0.458 | |
2fdd | 385 | Pol protein | / | 0.458 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
2uzu | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.458 | |
3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.458 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.458 | |
1bx6 | BA1 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.457 | |
1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.457 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
1zhw | HC2 | Oxysterol-binding protein homolog 4 | / | 0.457 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.457 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.457 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3h9f | 92M | Dual specificity protein kinase TTK | 2.7.12.1 | 0.457 | |
3ml9 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
4eqc | XR1 | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.457 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
1cjc | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.456 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.456 | |
2vo0 | M03 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
2xye | CXG | Gag-Pol polyprotein | / | 0.456 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
3eek | 53S | Uncharacterized protein | / | 0.456 | |
3gcp | SB2 | Mitogen-activated protein kinase 14 | / | 0.456 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
3obg | SB2 | Mitogen-activated protein kinase 14 | / | 0.456 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.456 | |
4axd | ANP | Inositol-pentakisphosphate 2-kinase | 2.7.1.158 | 0.456 | |
4bae | RWX | DNA gyrase subunit B | / | 0.456 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.456 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.456 | |
5fkn | TDC | Tetracycline repressor protein class D | / | 0.456 | |
1chw | HXC | Chalcone synthase 2 | 2.3.1.74 | 0.455 | |
1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.455 | |
2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.455 | |
3rin | I2O | Mitogen-activated protein kinase 14 | / | 0.455 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.455 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.455 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.455 | |
4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.455 | |
1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2j4d | FAD | Cryptochrome DASH, chloroplastic/mitochondrial | / | 0.454 | |
3dcv | 55E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.454 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.454 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.454 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.454 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
4cta | ATP | CinA-like protein | / | 0.454 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.454 | |
4l06 | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.454 | |
4pd6 | URI | Nucleoside permease | / | 0.454 | |
1ee0 | CAA | 2-pyrone synthase | / | 0.453 | |
1hk4 | T44 | Serum albumin | / | 0.453 | |
1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.453 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.453 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.453 | |
2vtb | FAD | Cryptochrome DASH, chloroplastic/mitochondrial | / | 0.453 | |
2y8q | ADP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.453 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.453 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.453 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.453 | |
4bur | NAD | Apoptosis-inducing factor 1, mitochondrial | 1.1.1 | 0.453 | |
4h1m | 0YJ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.453 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.453 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.453 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
1lp6 | C5P | Orotidine 5'-phosphate decarboxylase | 4.1.1.23 | 0.452 | |
1npa | 3NH | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
1npw | LGZ | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
1s9j | BBM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.452 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.452 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
1zgd | NAP | Chalcone reductase | / | 0.452 | |
2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.452 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
3c96 | FAD | Flavin-containing monooxygenase | / | 0.452 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.452 | |
4fyo | 0VF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.452 | |
4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.452 | |
1lol | XMP | Orotidine 5'-phosphate decarboxylase | 4.1.1.23 | 0.451 | |
1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.451 | |
2a7r | 5GP | GMP reductase 2 | / | 0.451 | |
2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.451 | |
2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.451 | |
3dqw | AGS | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.451 | |
3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.451 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.451 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.451 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.451 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.451 | |
5itz | LOC | Tubulin beta-2B chain | / | 0.451 | |
1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.450 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
2cdu | FAD | NADH oxidase | / | 0.450 | |
2etr | Y27 | Rho-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
2ph5 | NAD | Homospermidine synthase | / | 0.450 | |
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 0.450 | |
2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.450 | |
2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.450 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.450 | |
3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.450 | |
3swr | SFG | DNA (cytosine-5)-methyltransferase 1 | 2.1.1.37 | 0.450 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.450 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.450 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.450 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.450 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
4jaq | COA | Alpha-pyrone synthesis polyketide synthase-like Pks11 | 2.3.1 | 0.450 | |
1dg5 | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
1kyz | FER | Caffeic acid 3-O-methyltransferase | 2.1.1.68 | 0.449 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.449 | |
2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.449 | |
2oal | FAD | Flavin-dependent tryptophan halogenase RebH | 1.14.19.9 | 0.449 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
2qbl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.449 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.449 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
3s56 | ROC | Protease | / | 0.449 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.449 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.449 | |
4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.449 | |
4hjf | C2E | GGDEF family protein | / | 0.449 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.449 | |
4jx1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.449 | |
4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
1gp5 | DH2 | Leucoanthocyanidin dioxygenase | 1.14.11.19 | 0.448 | |
1ivq | 0PX | Gag-Pol polyprotein | / | 0.448 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
1rrm | APR | Lactaldehyde reductase | 1.1.1.77 | 0.448 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.448 | |
2ibz | SMA | Cytochrome b | / | 0.448 | |
2nnh | REA | Cytochrome P450 2C8 | / | 0.448 | |
2oye | IM8 | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.448 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.448 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
2xau | ADP | Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP43 | 3.6.4.13 | 0.448 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.448 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.448 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.448 | |
4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
4wbb | ADP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
4xiw | AZM | Carbonic anhydrase, alpha type | / | 0.448 | |
5eku | SAH | Arginine N-methyltransferase, putative | / | 0.448 | |
1bl7 | SB4 | Mitogen-activated protein kinase 14 | / | 0.447 | |
1im2 | ADP | ATP-dependent protease ATPase subunit HslU | / | 0.447 | |
1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.447 | |
1np7 | FAD | Cryptochrome DASH | / | 0.447 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
1zhz | ERG | Oxysterol-binding protein homolog 4 | / | 0.447 | |
2b5v | NAP | Glucose 1-dehydrogenase | / | 0.447 | |
2gek | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.447 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.447 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
2pul | ACP | Methylthioribose kinase | 2.7.1.100 | 0.447 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.447 | |
2y3r | TIR | TamL | / | 0.447 | |
3e8c | G96 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
3el5 | 1UN | Gag-Pol polyprotein | / | 0.447 | |
3fgo | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.447 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.447 | |
3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
3sa0 | NRA | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.447 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.447 | |
4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4gu6 | 10N | Focal adhesion kinase 1 | 2.7.10.2 | 0.447 | |
4h98 | 14Q | Uncharacterized protein | / | 0.447 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.447 | |
4kla | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.447 | |
4l03 | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.447 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
1iwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
1m9r | INE | Nitric oxide synthase, endothelial | 1.14.13.39 | 0.446 | |
1mes | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
1nr5 | NAD | Pentafunctional AROM polypeptide | / | 0.446 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.446 | |
2bpz | 3IN | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
2k62 | ITL | Fatty acid-binding protein, liver | / | 0.446 | |
2pwc | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.446 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.446 | |
3k3b | ADP | Kinesin-like protein KIF11 | / | 0.446 | |
3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.446 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
3upj | U03 | Gag-Pol polyprotein | / | 0.446 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.446 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.446 | |
4dsc | A8S | Abscisic acid receptor PYL3 | / | 0.446 | |
4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.446 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.446 | |
4lj7 | MNT | Chaperone protein ClpB | / | 0.446 | |
4n6h | EJ4 | Delta-type opioid receptor | / | 0.446 | |
4n9w | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.446 | |
4xxv | NAD | 3-isopropylmalate dehydrogenase | / | 0.446 | |
5jqb | IBP | Envelope glycoprotein | / | 0.446 | |
4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.446 | |
1mer | DMQ | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.445 | |
1yqj | 6NP | Mitogen-activated protein kinase 14 | / | 0.445 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.445 | |
2yis | YIS | Mitogen-activated protein kinase 14 | / | 0.445 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.445 | |
3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.445 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.445 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
4a9m | P9M | Bromodomain-containing protein 2 | / | 0.445 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.445 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.445 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
4g3s | UD1 | Bifunctional protein GlmU | / | 0.445 | |
4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.445 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.445 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.445 | |
6gsw | GPS | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.445 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.445 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
1t86 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
2ojf | 4PY | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2woe | AR6 | ADP-ribosyl-[dinitrogen reductase] glycohydrolase | 3.2.2.24 | 0.444 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2yfe | YFE | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
2zbz | VDX | Vitamin D3 dihydroxylase | / | 0.444 | |
3aid | ARQ | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.444 | |
3lu8 | IQX | Serum albumin | / | 0.444 | |
3opd | HIE | Heat shock protein 83 | / | 0.444 | |
3os3 | 3OS | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.444 | |
3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.444 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
3r9n | Z68 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3ujl | A8S | Abscisic acid receptor PYL2 | / | 0.444 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.444 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.444 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.444 | |
4s34 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
5hi6 | MTX | Dihydrofolate reductase | / | 0.444 | |
6upj | NIU | Gag-Pol polyprotein | / | 0.444 | |
1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.443 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.443 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.443 | |
2jds | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.443 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
2q6c | HR1 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.443 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.443 | |
2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.443 | |
3clh | NAD | 3-dehydroquinate synthase | 4.2.3.4 | 0.443 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3lzv | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.443 | |
3ort | AGS | Serine/threonine protein kinase | / | 0.443 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4j5j | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.443 | |
4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.443 | |
4m15 | ADP | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.443 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.443 | |
4nr4 | 2LK | CREB-binding protein | / | 0.443 | |
4nt0 | 3DU | Orotidine 5'-phosphate decarboxylase | 4.1.1.23 | 0.443 | |
4o2z | 046 | Mitogen-activated protein kinase | / | 0.443 | |
4s32 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
1e3v | DXC | Steroid Delta-isomerase | 5.3.3.1 | 0.442 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
1hvh | Q82 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.442 | |
1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.442 | |
2cd8 | PXI | Cytochrome P450 monooxygenase PikC | / | 0.442 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
2hnz | PC0 | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
2rgj | FAD | Flavin-containing monooxygenase | / | 0.442 | |
2wle | COA | Polysialic acid O-acetyltransferase | / | 0.442 | |
2xy9 | 3ES | Angiotensin-converting enzyme | 3.2.1 | 0.442 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.442 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.442 | |
3flq | 891 | Mitogen-activated protein kinase 14 | / | 0.442 | |
3ix9 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.442 | |
3q92 | XNB | Ketohexokinase | / | 0.442 | |
3v04 | V04 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.442 | |
3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.442 | |
4d58 | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4iwc | 1GV | Estrogen receptor | / | 0.442 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.442 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
1oh0 | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.441 | |
1rc4 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1tkz | H16 | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
1ydt | IQB | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
2gm1 | 2AZ | Kinesin-like protein KIF11 | / | 0.441 | |
2jko | BIJ | Focal adhesion kinase 1 | 2.7.10.2 | 0.441 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.441 | |
3frd | DHF | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
3lxi | CAM | Cytochrome P450 | / | 0.441 | |
3njo | P2M | Abscisic acid receptor PYR1 | / | 0.441 | |
3nnu | EDB | Mitogen-activated protein kinase 14 | / | 0.441 | |
3oib | FDA | Putative acyl-CoA dehydrogenase | / | 0.441 | |
3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
3pt6 | SAH | DNA (cytosine-5)-methyltransferase 1 | 2.1.1.37 | 0.441 | |
3qa2 | XNA | Ketohexokinase | / | 0.441 | |
3ua5 | 06X | Cytochrome P450 2B6 | 1.14.13 | 0.441 | |
3zps | EQM | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
3zrk | ZRK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
4an2 | EUI | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.441 | |
4bew | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.441 | |
4dpw | AGS | Mevalonate diphosphate decarboxylase | / | 0.441 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.441 | |
4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.441 | |
4jap | COA | Alpha-pyrone synthesis polyketide synthase-like Pks11 | 2.3.1 | 0.441 | |
4l49 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
4l4c | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.441 | |
9hvp | 0E9 | Gag-Pol polyprotein | / | 0.441 | |
1me8 | RVP | Inosine-5'-monophosphate dehydrogenase | / | 0.440 | |
1mp4 | UPG | Glucose-1-phosphate thymidylyltransferase | / | 0.440 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.440 | |
1owp | FAD | Deoxyribodipyrimidine photo-lyase | 4.1.99.3 | 0.440 | |
1qvr | ANP | Chaperone protein ClpB | / | 0.440 | |
1sn5 | T3 | Transthyretin | / | 0.440 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
2fzi | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
2oxt | SAM | Genome polyprotein | / | 0.440 | |
2v51 | LAB | Actin, alpha skeletal muscle | / | 0.440 | |
2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
2xka | GSP | Cell division protein FtsZ | / | 0.440 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
3a14 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.440 | |
3ckt | YDP | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
3etg | GWD | Glutamate dehydrogenase 1, mitochondrial | 1.4.1.3 | 0.440 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
3tm0 | ANP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.440 | |
3zcw | 4A2 | Kinesin-like protein KIF11 | / | 0.440 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
4b1v | LAB | Actin, alpha skeletal muscle | / | 0.440 | |
4cy8 | FDA | 2-hydroxybiphenyl-3-monooxygenase | / | 0.440 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.440 | |
4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.440 | |
4k4p | 3TL | Gag-Pol polyprotein | / | 0.440 | |
5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.440 |